Mark A. Emkes
Mark A. Emkes's purchase track record
Mark A. Emkes has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/6/2025 | GEF | $168K | +13.8% | +10.7% | +13.3% |
| 3/8/2022 | CXW | $85K | +55.5% | +11.4% | -6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Raymond James Upgrades Greif to Outperform with $90 Target. Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.
Transaction History
| CXW | ▼ Sell | Open Market | 30,000 | $1.0M | 8/24/2026 | View on chart |
| GEF | ▼ Sell | Open Market | 3,000 | $261K | 8/3/2026 | View on chart |
| CXW | ▲ Buy | Grant | 2,824 | $60K | 5/14/2026 | View on chart |
| GEF | ▲ Buy | Grant | 2,143 | $0 | 2/23/2026 | View on chart |
| CXW | ▲ Buy | Grant | 8,351 | $0 | 2/18/2026 | View on chart |
| CXW | ▲ Buy | Grant | 2,737 | $60K | 5/15/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 3,000 | $168K | 3/6/2025 | View on chart |
| GEF | ▲ Buy | Grant | 2,668 | $0 | 2/24/2025 | View on chart |
| CXW | ▲ Buy | Grant | 8,098 | $0 | 2/19/2025 | View on chart |
| CXW | ▼ Sell | Open Market | 16,000 | $363K | 11/22/2024 | View on chart |
| CXW | ▲ Buy | Grant | 3,356 | $50K | 5/15/2024 | View on chart |
| GEF | ▲ Buy | Grant | 2,247 | $0 | 2/26/2024 | View on chart |
| CXW | ▲ Buy | Grant | 9,247 | $0 | 2/16/2024 | View on chart |
| CXW | ▲ Buy | Grant | 5,447 | $50K | 5/10/2023 | View on chart |
| GEF | ▲ Buy | Grant | 2,016 | $0 | 2/28/2023 | View on chart |
| CXW | ▲ Buy | Grant | 12,784 | $0 | 2/17/2023 | View on chart |
| GEF | ▼ Sell | Open Market | 6,000 | $374K | 6/29/2022 | View on chart |
| CXW | ▲ Buy | Grant | 4,803 | $50K | 5/12/2022 | View on chart |
| CXW | ▲ Buy | Open Market | 10,000 | $85K | 3/8/2022 | View on chart |
| GEF | ▲ Buy | Grant | 2,469 | $0 | 3/1/2022 | View on chart |
| CXW | ▲ Buy | Grant | 13,720 | $0 | 2/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
CoreCivic Sets Q3 2026 Earnings Date Amid Sector News
CoreCivic announced the dates for its 2026 third-quarter earnings release and conference call. This announcement appears alongside broader industry news, including a $950 million deal where the Department of Homeland Security purchased three detention facilities from The Geo Group. The stock is currently trading near its support level, with analysts maintaining an average price target of $41.80.
CoreCivic Sets Q3 2026 Earnings Date Amid Sector News. CoreCivic announced the dates for its 2026 third-quarter earnings release and conference call. This announcement appears alongside broader industry news, including a $950 million deal where the Department of Homeland Security purchased three detention facilities from The Geo Group. The stock is currently trading near its support level, with analysts maintaining an average price target of $41.80.